Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Guidelines vs. Rules: Deviating from the Standard of Care When Strong Principles Lead You There
Author
Howard (Jack) West, MD

This week I found myself recommending surgery for a patient who had already undergone chemo and chest radiation, then more chemotherapy and more radiation, for limited stage small cell lung cancer (SCLC).   To be clear, there is no standard role for surgery in this setting, no data to support it, and I can’t recall a situation in which I’ve felt surgery was an appropriate approach for previously treated SCLC. Nevertheless, his case was unique enough that not only did I feel surgery is clearly a compelling idea, but our multidisciplinary tumor board reviewed his situation and emerged with a clear consensus favoring surgery, at least if some additional components of his work up supports it.

 

Though I and other experts here try to make decisions based on the best evidence and the national guidelines derived from them, we also recognize that there are special cases for which there is no good evidence to inform our decisions. In such cases, it’s important to recognize that guidelines are not the same as rules, and that it can be perfectly acceptable, even ideal, to go beyond the guidelines when the right principles lead us to a more “creative” approach.

The patient in question is a 72 year old longtime smoking man who was diagnosed with limited stage SCLC in his right upper lobe in June of 2012. After receiving standard chemo and radiation to his chest tumor, he continued to have a persistent primary tumor visible on imaging.  He was actually treated at another facility and went on to receive additional chemo for several months in a way that I don’t think I would have done, since it wasn’t clear whether this residual primary tumor represented viable cancer or dead/dying cancer after extensive treatment. Regardless, he continued to have repeated scans (PET/CT scans on every occasion, as is often done but often leads to very ambiguous findings and, I believe, a temptation to make unconventional decisions) that tempted his oncologist to keep advocating chemo, which the patient had a lot of difficulty tolerating, eventually developing neuropathy and weakness so severe he couldn’t walk without falling down and needed to use a walker to get around.

After getting PCI and his scans continuing to show a residual PET avid primary cancer in the right upper lobe, he was referred to a thoracic surgeon I work with, who carefully considered the potential value of surgery but declined to do it because he felt that this man was too debilitated to safety tolerate the rigors of it. 

He was then referred to a radiation oncologist for additional radiation and received stereotactic body radiation therapy (SBRT)/Cyber Knife to the residual mass, based on a presumption that it represents ongoing viable cancer.  The treatment was completed in late July of 2013.

Since then, he has continued to be followed by another oncologist, who has continued to do regular PET/CT scans for surveillance. These have been essentially stable, but with residual metabolic activity and a visible mass, his oncologist now favors surgery to remove it.  Over the past nearly 6 months with no treatment, this gentleman has recovered from many of the difficult side effects and has returned to a much more active life, no longer needing a walker, though still far weaker than he started.

I saw the patient as a second opinion, reviewed all of these findings and discussed them with the surgeon, and we agreed that if a biopsy proves there to be residual viable cancer and a repeat brain MRI shows no new brain metastases, surgery in this very unusual case makes sense.   Part of our confidence about the potential utility of surgery comes from the fact that it has been over 18 months since his diagnosis and about 9 months since his last chemotherapy, and his cancer still hasn’t demonstrated progression elsewhere. This makes us realistically hopeful that we won’t see new spread in the weeks or months just after surgery.

You might ask why we’d be sticklers about a repeat biopsy.  If interpreting a PET/CT after standard chemo and radiation is difficult, we’re learning that interpreting a PET/CT after SBRT approaches impossible. Specifically, we’re seeing that treated lesions look for all the world like residual viable cancer on a PET/CT even many months after they’ve been treated but may well just be treated, dead cancer. How do we know? Because we reviewed results from a surgery in a very similar case just a week ago who underwent surgery for a presumed residually PET-avid cancer after SBRT to an NSCLC lesion, with pathology subsequently showing no viable cancer at all. 

A key principle I always try to follow is to treat the situation you’re seeing, rather than being absolutely limited by the tissue diagnosis. Because cancer mutates over time, it doesn’t feel a need to conform to rigid rules, so neither should we.  If an extremely unusual SCLC leads us to a situation in which surgery makes sense, we shouldn’t rule out the possibility just because there’s no place for it in the guidelines, which are for more usual cases.  We just need to be diligent about not going far outside of the guidelines if it actually doesn’t make sense, such as if we don’t actually know that there’s viable cancer or there’s any evidence of disease outside of the primary tumor.

This case discussion isn’t meant to imply that we should be doing surgery after chemo and radiation for SCLC. I do mean to convey, however, that the general approaches we recommend as clear standards of care aren’t meant to be inviolable. In individual cases, a personalized approach can be very appropriate, even if it transgresses the prevailing standards of care.

Next Previous link

Previous PostNext Post

Related Content

Image
Terapias Dirigidas de Cancer de Pulmón 2024
Video
La Dra. Estelamari Rodríguez presenta información básica sobre el NSCLC EGFR+ y analiza la importancia de las pruebas de biomarcadores en el cáncer de pulmón y ofrece una descripción general de las opciones de tratamiento para la enfermedad EGFR+.  Para ver la playlist completa, de click aquí.        
Image
2024-25 patient perspectives header
Article
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial.  We want to hear from you!
Image
HPV Advances
Video
In this video series, Dr. Paul Romesser discusses recent advances in HPV related cancers, including treatment options, vaccination recommendations and patient perspectives.   To watch the full playlist click here.  

Forum Discussions

Hi Bluebird,  Welcome to GRACE.  I'm sorry you're going through this scare and hope it's just inflammation or from an infection you didn't know you had. 

 

A CT would be...

Radiation + Brain Operation has just been discarded due to high risk. They will double Tagrisso dosis and then wait to see if it works, then try traditional Chemo. I would...

Hi and welcome to GRACE.  I'm sorry to know you are entering a new stage.  I'm not about to comment just now but wanted to let you know I see your...

Edit to say, we can't give advice but we can comment with views and facts.  :)

 

My first thought is to ask if she has been seen at a large...

Hi Barbro, Welcome to GRACE. I'm sorry you're worrying about this. We aren't able to give feedback on scan reports. Interpreting scan reports in this setting is not only unethical but...

Thank you, Janine, for answering so rapidly. I am aware that my nodules are small, but they scare me all the same. Your words that nodule measurements may vary somewhat when...

Hi Barbro,  I'm sorry you're worrying about this, and don't feel like you can discuss this with your doctor.  Speak to your doctor about this.  Let them know your worries and...

Recent Comments

JOIN THE CONVERSATION
what a disgrace doctor is
By ROSHAN_bhatia on
Hi Bluebird,  Welcome to…
By JanineT GRACE … on
Hi Barbro,  I'm sorry you're…
By JanineT GRACE … on
General Lung/Thoracic Cancer
By Barbro Kristin… on